Meredith Emmerich's most recent trade in Xylem Inc was a trade of 5,739 Non-Qualified Stock Options (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xylem | Meredith Emmerich | EVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 5,739 | 5,739 | - | - | Non-Qualified Stock Options (Right to Buy) | |
| Xylem | Meredith Emmerich | EVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 1,610 | 5,605 (0%) | 0% | 0 | Common Stock | |
| Xylem | Meredith Emmerich | EVP & Pres, AW | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.19 per share. | 21 Oct 2025 | 841 | 3,992 (0%) | 0% | 147.2 | 123,787 | Common Stock |
| Xylem | Meredith Emmerich | SVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,721 | 3,721 | - | - | Non-Qualified Stock Options (Right to buy) | |
| Xylem | Meredith Emmerich | SVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 129.67 per share. | 05 Mar 2025 | 1,060 | 4,833 (0%) | 0% | 129.7 | 137,450 | Common Stock |
| Xylem | Meredith Emmerich | SVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 33,138 | 33,138 | - | - | Stock Options (Right to buy) | |
| Xylem | Meredith Emmerich | SVP & Pres, AW | Grant, award, or other acquisition of securities at price $ 132.54 per share. | 21 Oct 2024 | 3,772 | 3,772 (0%) | 0% | 132.5 | 499,941 | Common Stock |